The GreenScreen genotoxicity assay: a screening validation programme.
Mutagenesis
; 19(2): 105-19, 2004 Mar.
Article
in En
| MEDLINE
| ID: mdl-14981157
ABSTRACT
A yeast (Saccharomyces cerevisiae) DNA repair reporter assay termed the GreenScreen assay (GSA) is described. This is a novel, cost-effective genotoxicity screen, developed to provide a pre-regulatory screening assay for use by the pharmaceutical industry and in other applications where significant numbers of compounds need to be tested. It provides a higher throughput and a lower compound consumption than existing eukaryotic genotoxicity assays and is sensitive to a broad spectrum of mutagens and, importantly, clastogens. We describe a simple, robust assay protocol and a validation study. The end-point of the test reflects the typically eukaryotic chromosomes and DNA metabolizing enzymes of yeast. The capacity for metabolic activation (MA) in yeast is limited compared with the mammalian liver or its extracts, but the assay does detect a subset of compounds that would require MA in existing genotoxicity tests. The GSA detects a different spectrum of compounds to bacterial genotoxicity assays and thus, together with an in silico structure-activity relationship (SAR) screen, and possibly a high throughput bacterial screen, would provide an effective preview of the regulatory battery of genotoxicity tests.
Search on Google
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Saccharomyces cerevisiae
/
Genetic Techniques
/
DNA Repair
Type of study:
Diagnostic_studies
/
Screening_studies
Language:
En
Journal:
Mutagenesis
Journal subject:
GENETICA MEDICA
/
SAUDE AMBIENTAL
Year:
2004
Document type:
Article
Affiliation country:
Reino Unido